Dublin, April 08, 2025 (GLOBE NEWSWIRE) -- The "Softgel Capsules Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to ResearchAndMarkets.com's offering.
The Softgel Capsules Market was valued at USD 9.3 billion in 2024, and is projected to reach USD 18.4 billion by 2034, rising at a CAGR of 7.2%.
Increasing consumption of nutraceuticals such as vitamins, omega-3 fatty acid supplements, and herbal medicines is a primary factor driving market growth. These products offer easier consumption and faster absorption compared to traditional medicines, making them a preferred choice among consumers.
Additionally, advancements in softgel capsule manufacturing, such as the introduction of plant-based alternatives like potato starch, hydroxypropyl methylcellulose (HPMC), and pullulan, are further boosting industry growth. With a heightened focus on immune system boosters and dietary supplements, particularly after the pandemic, there has been a surge in demand for softgel capsules. Growing awareness about preventive healthcare and a shift toward healthier lifestyles have contributed to the increased adoption of dietary supplements, adding to the market's growth momentum.
Based on type, the market is segmented into vegetarian and gelatin-based capsules, with the gelatin-based segment dominating the market, valued at USD 8.4 billion in 2024. These capsules provide better bioavailability, faster onset of action, and protection against environmental factors like light, air, and moisture, making them preferable over traditional tablets and capsules.
The health and dietary supplements segment accounted for 65.4% of the market in 2024 and is projected to grow at a CAGR of 7.5% during the forecast period. Increasing demand for vitamins, minerals, and omega-3 supplements to boost immunity and improve overall health is driving this segment. The trend toward preventive healthcare has led consumers to include supplements in their daily routines to prevent chronic conditions such as cardiovascular diseases and osteoporosis. Rising healthcare costs have also encouraged the adoption of supplements as a cost-effective measure to manage long-term health, further fueling the demand for softgel capsules. Technological advancements have streamlined the manufacturing process, enabling the inclusion of a wider range of ingredients in softgel formulations, contributing to market growth.
The human segment led the market, generating USD 8.4 billion in 2024, and is projected to reach USD 16.4 billion by 2034. An aging population, particularly in developed nations, has fueled demand for easy-to-swallow and convenient medication forms like softgel capsules. The growing popularity of vitamins, minerals, and herbal supplements among health-conscious consumers has further boosted market growth. Pharmaceutical companies continue to embrace softgel formulations for their aesthetic appeal and consumer preference, strengthening the industry's growth trajectory.
Nutraceutical companies held a significant share of the market in 2024 and are expected to reach USD 8.4 billion by 2034. Rising consumer awareness about health and wellness, coupled with the proliferation of direct-to-consumer (DTC) models and e-commerce platforms, has expanded the reach of nutritional supplements, increasing demand for softgel capsules. Regulatory agencies in different regions have supported the use of nutraceuticals by approving various health claims, paving the way for the development of innovative softgel formulations.
In North America, the U.S. held a prominent position in the market, valued at USD 3.6 billion in 2024. Increased consumer inclination toward self-medication and over-the-counter (OTC) supplements, combined with favorable regulatory frameworks and growing research and development funding, has fueled the market's expansion.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter's Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
Key Attributes
| Report Attribute | Details |
| No. of Pages | 140 |
| Forecast Period | 2024-2034 |
| Estimated Market Value (USD) in 2024 | $9.3 Billion |
| Forecasted Market Value (USD) by 2034 | $18.4 Billion |
| Compound Annual Growth Rate | 7.2% |
| Regions Covered | Global |
Key Topics Covered
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
2.1 Industry 360 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing demand for nutraceuticals
3.2.1.2 Growing prevalence of chronic ailments globally
3.2.1.3 Technological innovation in softgel manufacturing
3.2.1.4 Increasing shift towards gelatin free capsules
3.2.2 Industry pitfalls and challenges
3.2.2.1 Competition from alternative dosage forms
3.2.2.2 Stringent regulatory requirements
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2024
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, by Type, 2021-2034 ($ Mn)
5.1 Key trends
5.2 Gelatin based
5.3 Vegetarian capsules
Chapter 6 Market Estimates and Forecast, by Application, 2021-2034 ($ Mn)
6.1 Key trends
6.2 Health and dietary supplements
6.2.1 Vitamins
6.2.2 Enzymes
6.2.3 Omega
6.2.4 Minerals
6.2.5 Other health and dietary supplements
6.3 Prescription medicine
6.3.1 Antibiotics and antivirals
6.3.2 Anti-inflammatory drugs
6.3.3 Cough and cold drugs
6.3.4 Other prescription medicines
6.4 Other applications
Chapter 7 Market Estimates and Forecast, by Indication, 2021-2034 ($ Mn)
7.1 Key trends
7.2 Humans
7.3 Animals
Chapter 8 Market Estimates and Forecast, by End Use, 2021-2034 ($ Mn)
8.1 Key trends
8.2 Pharmaceutical companies
8.3 Nutraceutical companies
8.4 Veterinary industry
8.5 Other end use
Chapter 9 Market Estimates and Forecast, by Region, 2021-2034 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.4 Asia-Pacific
9.4.1 China
9.4.2 India
9.4.3 Japan
9.4.4 Australia
9.4.5 South Korea
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
Chapter 10 Company Profiles
10.1 Aenova Group
10.2 Capsugel (Lonza)
10.3 Captek Softgel International
10.4 Catalent
10.5 Curtis Health Caps
10.6 Delpharm Evreux
10.7 Estrellas
10.8 Eurocaps
10.9 Fuji Capsules
10.10 Guangdong Yichao Biological
10.11 Nutramax Laboratories
10.12 Patheon
10.13 Procaps Group
10.14 Sirio Pharma
For more information about this report visit https://www.researchandmarkets.com/r/nii9fu
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
